Levated Plasma Levels of Chemerin in Newly Diagnosed Type 2 Diabetes Mellitus with Hypertension

Mengliu Yang, Gangyi Yang, Jing Dong, Ying Liu, Haihong Zong, Hua Liu, Guenther Boden, Ling Li

Research output: Contribution to journalArticle

68 Scopus citations


Chemerin is a recently discovered metabolic regulator hormone. The pathophysiologic role of this hormone in humans remains unknown. In this study, we have compared plasma chemerin levels in patients with type 2 diabetes mellitus with or without hypertension and in control subjects. We also assessed the association of plasma chemerin with body composition and metabolic parameters in these subjects. Plasma chemerin levels were found to be markedly increased in patients with type 2 diabetes mellitus with hypertension as compared with patients with type 2 diabetes mellitus and normal controls (P < 0.01). Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA 1 c were independently related factors influencing plasma chemerin levels. The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)883-886
Number of pages4
JournalJournal of Investigative Medicine
Issue number7
Publication statusPublished - Jan 1 2010



  • Key Words chemerin
  • body composition
  • hypertension
  • metabolic parameters
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this